Subscribe
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
ESMO 2025 - Wrap-Up: Triple-Negative Breast Cancer
ASCO 2025 - Wrap-Up: Triple-Negative Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quiz
Press Releases
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma
Tanios S. Bekaii-Saab, MD
David F. and Margaret T. Grohne Professor of Novel Therapeutics for Cancer Research
Chair and Consultant, Division of Hematology and Medical Oncology
Professor, Mayo Clinic College of Medicine and Science, Scottsdale, AZ
Authored Articles
Deciding Between Triplet Therapy for the Treatment of Pancreatic Cancer: NALIRIFOX and FOLFIRINOX
Tanios S. Bekaii-Saab, MD
,
Shubham Pant, MD
,
Michael Pishvaian, MD, PhD
Interview with the Innovators
Videos
Read Article
Deciding Which Patients Are Best Suited for Various First-Line Pancreatic Cancer Treatment Options
Tanios S. Bekaii-Saab, MD
,
Shubham Pant, MD
,
Michael Pishvaian, MD, PhD
Interview with the Innovators
Videos
Read Article
Considerations for Selecting a First-Line Pancreatic Cancer Treatment
Tanios S. Bekaii-Saab, MD
,
Shubham Pant, MD
,
Michael Pishvaian, MD, PhD
Interview with the Innovators
Videos
Read Article
How the Cost of Cancer Treatments May Affect Treatment Decisions for Patients
Tanios S. Bekaii-Saab, MD
,
Shubham Pant, MD
,
Michael Pishvaian, MD, PhD
Interview with the Innovators
Videos
Read Article
Best Practices for Treating Adverse Events Associated With Pancreatic Cancer Therapies
Tanios S. Bekaii-Saab, MD
,
Shubham Pant, MD
,
Michael Pishvaian, MD, PhD
Interview with the Innovators
Videos
Read Article
Key Side Effects That May Occur With First-Line Treatments for Patients With Pancreatic Cancer
Tanios S. Bekaii-Saab, MD
,
Shubham Pant, MD
,
Michael Pishvaian, MD, PhD
Interview with the Innovators
Videos
Read Article
The Importance of Median Progression-Free Survival in Oncology Clinical Trials
Tanios S. Bekaii-Saab, MD
,
Shubham Pant, MD
,
Michael Pishvaian, MD, PhD
Interview with the Innovators
Videos
Read Article
Median Overall Survival of First-Line Treatments for Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC)
Tanios S. Bekaii-Saab, MD
,
Shubham Pant, MD
,
Michael Pishvaian, MD, PhD
Interview with the Innovators
Videos
Read Article
Evaluation of Patients for Pancreatic Cancer
Tanios S. Bekaii-Saab, MD
,
Shubham Pant, MD
,
Michael Pishvaian, MD, PhD
Interview with the Innovators
Videos
Read Article
Top Trending Articles
1.
Immunotherapy Helps Navy Veteran Beat Stage 4 Lung Cancer
2.
HOPA Highlights: What's New in 2025?
3.
Peer Navigation Intervention Aims to Boost Childhood Cancer Clinical Trial Participation
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
ESMO 2025 - Wrap-Up: Triple-Negative Breast Cancer
ASCO 2025 - Wrap-Up: Triple-Negative Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quiz
Press Releases
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma